Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Thoughts on this?

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Nov 29, 2021 12:35am

254 Views

Post# 34174695

RE:RE:RE:RE:RE:RE:RE:Thoughts on this?

I have seen a number of examples of small acquisitions taking over a year. Agree a simple acquisition could happen much quicker especially in a mature market. This is an emerging market and there are more risks and as a result the DD has more depth. Preclinical studies take time it's simply not going to happen quicker than a year IMO. Since it's likely a licensing deal there are also more terms to work out then with an acquisition and this appears to be the stage we are at.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"